Zydus Lifesciences Limited — Updates, 13-11-2025: Press Release
13-11-2025 | 07:01 pm
13-11-2025 | 07:01 pm
Zydus' Ahmedabad oncology injectable facility received two USFDA observations following a Pre-Approval Inspection for a new line. Critically, no data integrity issues were reported. Zydus will address findings swiftly to progress product approvals.
No comments yet. Be the first to comment!
